A personal essay and podcast episode explore life with long Covid
The good life you've worked hard to create suddenly comes crashing down. That's the theme of countless crime and mystery novels. It's also the reality for people like Rachel Hall-Clifford, for whom Covid-19 came calling in January 2022 and has never gone away. Millions of people in the United States and around the world are now living with long-term consequences of what may have initially been a mild bout of Covid-19. They experience a variety of seemingly unrelated issues, including extreme fatigue, brain fog, cardiovascular problems, migraine, and more. Hall-Clifford writes in a First Opinion essay, then eloquently explains in an episode of the First Opinion Podcast, how long Covid has changed her life as a wife, mother, friend, and medical anthropologist. If you enjoy listening to podcasts, I recommend you check out this one. On a different note, health care executive Hal Rosenbluth opens up about his life as a hypochondriac. Rosenbluth understands how this condition costs the U.S. health care system billions of dollars in unnecessary testing and treatment each year, and offers some solutions to the problem. A side note: While doing some fact-checking, I was curious about the name of this condition, which applies to people with excessive concern about their health, especially when accompanied by imagined symptoms. I'd expect something like this to start with "hyper," meaning too much, instead of "hypo," which means too little. It turns out it originally referred to the soft region of the body below (Greek: hupo) the ribs (Greek: khondros). Early physicians thought that this excessive worry was a type of melancholy that arose from the liver and spleen. And don't miss an account of why journals should retract articles — but are reluctant to act — by Richard Lynn that were written to further his notions of white supremacy. Those are only the tip of this week's First Opinion topics. You can read them all here. |
|
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2024, All Rights Reserved. | |
|
No comments